S-337395
/ Shionogi, Ube Corp
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
October 16, 2025
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
(clinicaltrials.gov)
- P2 | N=192 | Not yet recruiting | Sponsor: Shionogi
New P2 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections
July 10, 2024
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: Shionogi | Recruiting ➔ Completed
Trial completion
March 06, 2024
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: Shionogi | Not yet recruiting ➔ Recruiting
Enrollment open
February 21, 2024
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Shionogi
New P1 trial
1 to 4
Of
4
Go to page
1